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ABSTRACTS 
Compared to their terrestrial counterparts, marine microorganisms seem to be a 
relatively unexplored resource for novel bioactive metabolites. This thesis research 
aimed to discover new bioactive compounds of pharmaceutical value from the 
secondary metabolites produced by marine bacteria and fungi . The ecological role of 
marine bacteria involving the production of antibacterial metabolites was also 
investigated. 
This thesis describes three different studies, all of which are focused on the 
secondary metabolites produced by marine bacteria or fungi . First, bacteria-bacteria 
antagonism as a mechanism limiting the spread of Vibrio cholerae in the ocean was 
investigated using a marine particle-attached bacterial model, SWAT3, for its ability to 
prevent the colonization of particles and hence the growth of V. cholerae, by producing 
a antibacterial agent, andrimid. Second, the biosynthesis of CNC352.223, a novel 
metabolite derived from a marine fungus was explored using stable isotopic feeding 
experiments. Third, a marine-derived Halobacillus sp. culture C42, was investigated 
for its production of bacterial cell-cell signaling-antagonists since compounds 
possessing this type of activity may lead to a new generation of antibiotics. Two 
bioactive metabolites were isolated from C42 culture. Their bioactivity against bacterial 
cell-cell communication system was also examined. 
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CHAPTERl 
Bacteria-Bacteria Antagonism as a Mechanism Limiting 
the Spread of Vibrio cholerae in the Ocean 
Evidence suggests that Vibrio cholerae, the etiologic agent of cholera, 
proliferates much faster at higher sea surface temperatures (Colwell, 1996). Thus, there 
is a concern that global climate warming will lead to increases in the frequency and 
geographic distributions of cholera epidemics (Harvell et al., 2002; Epstein, 1999). 
However, the mechanisms for the temperature-dependent abundance of V. cholerae in 
ocean are unknown. This chapter describes a study designed to explore whether 
autochthonous marine bacteria play a role in limiting the proliferation of V. cholerae 
through bacteria-bacteria antagonism. Further, this study sought to explore the effect of 
temperature on these types of bacterial interactions. 
The investigation described in this chapter was conducted in collaboration with 
Dr. Farooq Azam, Dr. Douglas Bartlett, and Mr. Eric Zamora of the Scripps Institution 
of Oceanography, UCSD, and Dr. Richard Long at Texas A&M University. The 
investigation can be roughly divided into two parts. The first part, conducted by my 
collaborators listed above, included collecting and screening a diverse panel of marine 
bacteria for their anti-V. cholerae activity, building a model system employing bacteria 
labeled with Green Fluorescent Protein (GFP), and conducting V. cholerae colonization 
inhibition assays. A brief review of these components will be presented in the 
Introduction. My contribution to this study was the identification of the chemical 
mechanisms behind the observed bacteria-bacteria antagonistic interactions, and is 
described in detail in the ensuing sections of this chapter. 
1 
1.1 Introduction 
The Gram-negative bacterium Vibrio cholerae is notorious for its pathogenic 
biotypes that cause the severe and sometimes fatal dirraheal disease known as cholera. 
In 1883, Robert Koch isolated the classical biotype of V. cholerae (V. cholerae 01) 
which caused the first six pandemics of cholera lasting until 1923 (Madigan et al., 
2003a). The seventh outbreak of cholera started in 1961 and several more pathogenic 
biotypes, notably V. cholerae Ol El Tor, V. cholerae non 01, and V. cholerae 0139, have 
since been discovered (Colwell, 1996; Ramamurthy et al., 1993; Shimada et al., 1993; 
Waldor et al., 1994). V. cholerae is an aquatic bacterium, and people consuming 
contaminated water are in danger of becoming infected (Madigan et al., 2003a). 
Pathogenic biotypes of V. cholerae proliferate and transport on marine particles, 
especially zooplankton. These associations assist V. cholerae in proliferating quickly 
during plankton blooms (Colwell 1996). Transport of V. cholerae in the ballast water of 
cargo ships is a concern for the introduction of the pathogen to previously unaffected 
coastlines (Ruiz et al. , 2000). 
The frequency of cholera outbreaks has been linked with increases in sea surface 
temperatures (Colwell, 1996). For example, cholera outbreaks have followed the sea 
surface temperature elevations associated with El Nino-Southern Oscillation (ENSO) 
events (Pascual et al., 2000). Thus, there is a concern that global climate change may 
lead to the emergence and resurgence of cholera pandemics. However, the reasons for 
rapid proliferation of V. cholerae during ocean warming events still remained 
undiscovered. 
2 
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It was previously reported that over 50% of marine bacteria exhjbit antagonistic 
activity against other marine strains (Long & Azam 2001). Considering this pervasive 
antibiosis in nature, it was hypothesjzed by Dr. Long and Azam that antagonistic 
behavior by iniligenous marine bacteria might limit colonjzation of marine particles by 
V. cholerae and thus its rapid proliferation in marine ecosystems. Dr. Richard Long and 
coworkers tested bacteria-bacteria antagonism as a possible mechanism to retard the 
proliferation of V.cholerae. In this study, 74 marine bacterial isolates representing 
phylogenetically diverse species of cultivable marine bacteria were tested for 
antagonistic activity against eight biotypes (both clinical and environmental) of V. 
cholerae. Both particle-attached and free living bacterial species were examined. A 
modified Burkholder inhibition assay was used (Long & Azam 2001). Briefly, growing 
cultures of test isolates were spotted onto lawns of V. cholerae imbedded in soft ZoBell 
2216 agar, and then zones of growth inhibition were measured after an incubation 
period. At 20 °C, a mean of 23% of the particle-attached marine bacteria inhibited the 
growth of V. cholerae while only 6% of free-living bacteria showed similar antagonjstic 
behavior (Table 1.1). Clinical and environmental biotypes of V. cholerae were equally 
inhibited, including both classical and El Tor strains. Furthermore, the results were 
temperature dependent. Antagonistic interactions decreased dramatically when the 
assay was increased to 30 °C. 
SW A T3 (Sea Water ATtached 3), a particle attached marine Vibrio sp., was 
selected as a model strain to study the effects of bacteria-bacteria antagonism on 
particle colonization by V. cholerae. SW AT3 displayed a temperature-dependent 
antagonjstic activity against the V. cholerae panel (Table 1.2). GFP-producing mutants 
3 
of SWAT3 were created by mutagenesis with a TnlO-based transposon derivative 
containing a promoterless-green fluorescent protein (Stretton et al. , 1998). The GFP-
mutants could be microscopically distinguished from V. cholerae. SWAT3-4 and 
SW AT3-111 were selected for further study from the 2000 mutants screened due to 
their (1) strong GFP signal and (2) ability (SWAT3-4) or inability (SWAT3-111) to 
antagonize the growth of V. cholerae N16961 (Figure 1.1). Both mutants displayed 
similar growth properties as the wild type. 
The mutant strains were next examined for their ability to inhibit the 
colonization of model particles by V. cholerae Nl 6961. Sterile seawater Petri dishes 
including nutrient-enriched, agarose particles were inoculated with one of the SW AT3 
mutants and incubated over night. The cultures were then inoculated with V. cholerae. 
The density of SW AT3 on the particles at the time of V. cholerae inoculation was 108 
mL-1, which falls within the range of bacterial density on marine particles (107 - 1010 
mL-1; Alldredge, 1986). V.cholerae was also inoculated into a control Petri dish with 
sterile agarose particles. The antagonistic mutant, SWAT3-4, completely inhibited the 
colonization of particles by V. cholerae, while particles in the presence of the non-
antagonistic mutant (SW AT3-111) had similar levels of attached V. cholerae as the 
control (Fig 1.2). The experiment was then repeated with particles embedded with 
freeze-thawed-lysed cells of the dinoflagellate Lingulodinium polyedrum with similar 
results . 
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Table 1.1 
The Effect of Temperature on Vibrio cholerae Inhibition by Marine Bacteria 
20 °C 30 °C 
V. cholerae strain 1 Attached Free-Ii vi n_g_ Attached Free-Ii vi n_g_ 
N16961 22.9 3.2 20 0 
01 22.9 3.2 8.6 0 
139 17.1 6.5 17.1 0 
non01 22.9 6.5 17.1 0 
395 31.4 16.1 20 3.2 
1st case 25.7 6.5 14.3 0 
G2 22.9 3.2 11.4 3.2 
Dino 20 3.2 31.4 22.6 
Note. Numbers refer to the percent of particle-attached and free-living marine bacterial isolates that 
inhibited V. cholerae growth as determined by a modified Burkholder inhibition assay (see text). The assay 
was scored positive when a zone of inhibition was greater than 2 mm from the edge of the test isolate. 1 V. 
cholerae isolates Ve Nl6961 and Ve 0395 were gifts from John J. Mekalanos. Isolates VcOl, Vc0139, Ve 
NonOI and Ve 151 case are part of an unpublished strain collection of Leonardo Lizzaraga (CICSESE, 
Ensenda Mexico). Isolates Ve TP and Ve SIO are environmental strains isolated off Scripps Pier (Purdy et 
al.; manuscript in preparation; GenBank accession numbers A Y494843 & A Y494842) 
Table 1.2 
The Effect of Temperature on SW AT3 Antagonism Against Vibrio cholerae 
V. cholerae Strains 25 °C 30 °C 
N16961 5 mma Hazy Zoneb 
01 6mm None 
0139 6mm None 
Non01 5mm None 
1st Case 4mm Hazy Zone 
G2 7mm Hazy Zone 
Dino 4mm Haz_y_ Zone 
Note. "The numbers represent the radius from the edge of the SWAT3 colony to where the lawns become 
translucent. httazy Zone indicates minimal inhibition, with a clear lawn of less than 2 mm. 
5 
SWAT3-4 
SWAT3-wt SWAT3-111 
Control 
Figure 1.1. The Antagonistic Activity by SWAT3 Strains 
Note. Colonies of SWA TI-wt and GFP-mutants which inhibit (SWAT3-4) and do not inhibit (SWAT3-111) 
V. cholerae were spotted onto a lawn of V. cholerae N 16961 and incubated at 20 °C. 
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Figure 1.2. The Antagonistic Activity of SWAT3 Strains Against the Colonization of V. 
cholerae in Liquid 
Note. (A) Particle Colonization Assay set up. ZoBelJ agarose particles were inoculated with a SWA T3 GFP-mutant 
and then spotted onto glass slides. Slides were incubated in IOOkD filtered seawater with or without V. cholerae, 
formalin fixed, and stained with DAPI. V. cholerae abundance was determined by subtracting SW A T3 (GFP) counts 
from total bacteria (DAPI) counts. A second experiment used agarose particles embedded with lysed dinoflagellate 
cells (Lingulodinium polyedrum) in stead of nutrients. (B) Inhibition of V. cholerae colonization. Model particles 
were inoculated with either SWAT3-4 (fi lled circle) or SWA T3-l I I (fi lled square). Control blanks appear as open 
squares. Replicates (n=3) were removed at each time point, and error bars represent standard deviations. I, agarose 
particles amended with nutrients; and 2, agarose particles embedded with freeze-thaw-lysed cells of L polyedrum. 
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My role in this project was to investigate (1) the underlying chemical 
mechanisms of the observed bacteria-bacteria antagonism, and (2) the temperature 
dependency of these interactions. The model system comprising SW AT3-wt (wild 
type), SWAT3-4 and SWAT3-111 was chosen to help accomplish these objectives. 
Prior to my involvement in this project, my former lab partner Ms. Ying Wang had 
studied SWAT3 due to a broad-spectrum antagonism it displayed against a panel of 
other marine bacterial strains (Long & Azam, 2001). By way of bioassay-guided 
fractionation, she had isolated the previously described antibacterial agent andrimid 
(Fredenhagen et al., 1987; Needham et al., 1994; Singh et al., 1997) from crude extracts 
of SWAT3 fermentations (Wang, 2003a). My initial hypothesis was that the V. 
cholerae inhibition by SW AT3 was due to its production of andrimid. 
1.2 Methods and Results 
1.2.1 Isolation and Purification of Anti-Vibrio cholerae Metabolites Produced by 
SWAT3, a Marine Vibrio sp. 
A 39 L culture of SWAT3 grown in YP medium (also called ZoBell medium, 
consisting of 1 g of yeast extract and 5 g of peptone in 1 liter of filtered sea water) was 
extracted with ethyl acetate to give 1.96 grams of crude extract (Wang, 2003a). Solvent 
partitioning of the crude extract between water and, sequentially, trimethylpentane 
(TMP), dichloromethane (DCM), ethyl acetate (EtOAc), and butanol (BuOH) 
concentrated the antibacterial activity in the DCM fraction (1.5 g) (Wang, 2003a). 813 
mg of the DCM fraction was applied to column chromatography (Kontes® 100 x 25 mm 
column packed with Amberchrom® CG-16lm, Lot: 32510129) and eluted using 
8 
aqueous methanol in gradient concentrations: 50% (150 rnL) ~75% (150 rnL) ~90% 
(150 rnL) ~100% (300 rnL). The 90% methanol fraction yielded 82 mg of yellow 
amorphous solid which was further purified by reverse phase HPLC (X-Terra® Prep RP 
C 18 column, 100 x 19 mm, flow rate of 10 rnIJrnin, A.=292 nm) using gradient aqueous 
methanol 45% ~ 80% over 20 minutes. The major peak eluting at 15.3 minutes was 
collected and concentrated in vacuo to yield the active material as a yellow amorphous 
solid (33.9 mg, Figure 1.3). This substance was verified as pure andrirnid by 
comparison of its 1H NMR spectrum with literature values (Needham et al., 1994) 
(Figure 1.4; Table 1.3). 
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Figure 1.3. The Flow Chart of the Isolation of Andrimid from a 39 L SW A T3 Culture 
Note. The bold part was conducted as part of this thesis. The extraction and solvent partitioning steps were done by 
Ms. Ying Wang (Wang, 2003a). 
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Table 1.3 
Proton NMR Data of Andrimid in DMSO-d6 (400 MHz) 
Carbon oH Carbon oH Carbon oH Carbon oH 
1-NH 11.36 1' l" l"' 
2 2' 4.63 2" 2.66, 2.74 2'" 6.01 
3 3.92 3' 2.29 3" 5.27 3"' 6.99 
4 2.90 4' 0.74 4" 4"' 6.25 
5 5' 0.80 5" 7.29 5'" 6.52 
6 1.07 2'-NH 8.11 6" 7.29 6"' 6.17 
7" 7.19 7"' 5.90 
8" 7.29 8"' 1.77 
9" 7.29 
3"-NH 8.42 
1.2.2 Assessment of the Anti-Vibrio cholerae Activity of Andrimid 
The anti-Vibrio cholerae activity of purified andrimid was initially examined 
using a disk diffusion assay. V. cholerae was cultured in 10 mL broth (1 % NaCl + 1 % 
Tryptone) and incubated at 30 °C with shaking overnight. The next day, a loop of the 
culture was evenly streaked over the top of a solid agar plate (1 % NaCl+ 1 % Tryptone). 
Andrim.id was dissolved in methanol at 25 mg/mL and 20 µL was applied to a paper 
disk (BBL™, 6mm diameter). A second disk treated with 20 µL of pure methanol 
served as the control. After solvent evaporation, the two paper disks were applied to the 
inoculated agar plate and incubated at 30 °C overnight. Andrimid produced a clear 27 
mm zone of inhibition. No zone was observed for the control disk. 
A broth dilution assay was next performed to determine the IC50 (inhibitory 
concentration that results in a 50% reduction in growth) of andrimid versus V. cholerae. 
An overnight culture of V. cholerae was diluted with fresh culture medium to 
12 
( OD600=0.043 and then further diluted 10-fold. This diluted culture is hereafter referred 
to as cell suspension (CS). In 96-well microtiter plates, 120 µL aliquots of the CS were 
treated with four-fold serial dilutions of andrimid. Tetracycline, methanol, and fresh 
broth (1 % NaCl+l % Tryptone) were used as the antibiotic, solvent, and blank controls, 
respectively. Table 1.4 shows the assay plate set up. The final concentrations of 
andrimid, tetracycline and methanol in each well of the plate are shown in Table 1.5. 
Duplicate plates were then incubated at 28 °C overnight. The next day, the optical 
density of the treated cultures was measured at 630 nm. The percent growth of V. 
cholerae in response to andrimid was calculated using the following the equation: 
% growth = 100% X (ODsamp1e-ODblank) I (ODsolvenr-ODblank) (1) 
Figure 1.5 shows percent growth as a function of andrimid concentration. At 28 °C, V. 
cholerae was sensitive to andrimid with an IC50 of0.12 µM, slightly lower than 
tetracycline (0.13 µM). 
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Table 1.4 
The 4-Fold Serial Dilution Set Up Scheme for the Broth Dilution Assay 
I 2 3 4 s 6 7 8 9 10 11 12 
A ISSµLCS * ISS µL CS ISSµLCS ISS µL CS ISS µL CS 4x dilution 4x dilution 4x dilution 4x dilution 4x dilution ISS µL CS ISS µLCS 
+S µL +S µL +SµL +S µL +S µL from HI from H2 from H3 from H4 from HS +S µL + S µLMeOH 
...... 
Andrimid Andrimid Andrimid Andrimid Andrimid Tetracycline 
+>- B 120 µL CS 120 µL CS 120µLCS 120 µL CS 120 µL CS 120 µL CS 120 µL CS 120µLCS 120 µL CS 120µLCS 120 µL CS 120 µL CS 
c 120µLCS 120µLCS 120µLCS 120 µL CS 120 µL CS 120µLCS 120 µL CS 120 µL CS 120 µL CS 120 µL CS 120 µL CS 120 µLCS 
D 120 µL CS 120 µL CS 120µLCS 120µLCS 120 µLCS 120 µL CS 120µLCS 120 µL CS 120 µL CS 120 µL CS 120µLCS 120 µL CS 
E 120 µL CS 120 µLCS 120 µL CS 120µLCS 120 µL CS 120 µLCS 120µLCS 120 µL CS 120 µL CS 120 µLCS 120 µLCS 120 µL CS 
F 120µLCS 120 µL CS 120 µL CS 120µLCS 120 µL CS 120 µL CS 120 µL CS 120 µL CS 120µLCS 120 µL CS 120 µLCS 120 µL CS 
G 120 µL CS 120 µL CS 120 µL CS 120 µL CS 120 µL CS 120µLCS 120µLCS 120 µL CS 120µLCS 120 µL CS 120 µL CS 100 µL broth 
H 120µLCS 120 µL CS 120 µL CS 120µLCS 120µLCS 120µLCS 120 µL CS 120µLCS 120 µLCS 120µLCS 120 µL CS 100 µL broth 
Note. CS: cell suspension, diluted V. cholerae culture. Serial dilution was accomplished by transferring 40 µL of A I-AS to BI-BS, mixing, transferring 40 µL to CI-CS, 
and so on. 
-Vl 
Table 1.5 
The Concentration of the Samples in Each Well 
Andrimid (µM) 
1-5 
A 65.226 
B 16.307 
c 4.076 
D 1.019 
E 0.255 
F 0.064 
G 0.016 
H 0.004 
6-10 
0.001 
2.5x104 
6.25x10·5 
l.56xl0·5 
3.9xl0~ 
9.75x10·7 
2.44x10·7 
6.lxlO-:g-
T, line (µM) MeOH 
11 12 
64.982 3.125% (v/v) 
16.246 0.781% 
4.061 0.195% 
1.015 0.049% 
0.254 0.012% 
0.063 0.003% 
0.016 Blank 
0.004 Blank 
....... 
0\ 
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Figure 1.5. Sensitivity of V. cholerae to Andrimid at 28 °C (n=lO) 
-. - Tetracycline 
• Andrimid 
To explore the temperature dependency of SW AT3 antagonism of V. cholerae, a 
2-fold broth dilution assay was performed as described above, but incubated at two 
different temperatures: 24 °C and 30 °C. The IC50 of andrimid against V. cholerae was 
0.08 µMat 24 °C and 0.14 µMat 30 °C (Figure 1.6). This result did not show a 
significant difference between the two values, which suggested that temperature was not 
critical to the antibacterial potency of andrimid against V. cholerae. The slight 
differences in IC50 were likely due to faster growth of V. cholerae at higher 
temperatures. 
1.2.3 Exploration of the Relationship Between the Anti-V. cholerae Activity of 
SWAT3 and Its Andrimid Production 
The following experiments were conducted to determine if the differences in 
antagonistic behaviors between the GFP-mutants SW AT3-4 and SW AT3-111 related to 
their ability to produce andrimid. As previously discussed SW AT3-4 prevented the 
colonization of particles by V. cholerae while SW AT3-111 did not. SW AT3-wt (wild 
type), SW AT3-4, and SW AT3-111 were each cultured in 1 L of YP broth, and 
incubated at approximate 24 °C on a rotary shaker. After four days, the turbid, light 
yellow cultures were each filtered through Celite521 (ACROS ORGANISCS, lot: 
A016788001) to remove the cells, and the resulting clear supematants were then each 
extracted with 2 x 500 mL of ethyl acetate. The three ethyl acetate portions were dried 
over Na2S04 and then concentrated in vacuo. 
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Figure 1.6. Sensitivity of V. cholerae to Andrimid as a Function of Temperature 
These cultures yielded 84.3 mg of SW AT3-wt extract, 85.8 mg of SW AT3-4 
extract, and 74.7 mg of SWAT3-11 l extract, all three as light brown solids. 
Paper disk diffusion assays (as described above) showed that the SWAT3-wt 
and SW AT3-4 extracts equally inhibited the growth of V. cholerae (ZOI = 22 mm), 
while the SWAT3-11 l extract was inactive (Table 1.6). 
Table 1.6 
The Diameter of Antibacterial Zone Induced by SWAT3 Crude Extracts 
Test sam_E_le ~eOH Andrimid SWAT3-wt SWAT3-4 JSWAT3-111 
Diameter of the inhibitory 
zone( mm)* NIA 27 22 22 NIA 
Note. * The diameter of the paper disk (6 mm) was included. 
Following the assays, all three crude extracts were examined by analytical 
HPLC (Hitachi® equipped with L-7455 diode array detector, column: X-Terra® RP C18 
column, 3.0 x 100 mm) to examine the concentrations of andrimid in the crude extracts. 
Andrimid and three crude extracts were each dissolved in methanol at a concentration 
of 3.3 mg/mL. The HPLC analysis of all four samples were conducted using identical 
conditions: 10 µL of the injection volume, gradient aqueous methanol (with 0.1 % 
formic aicd) (45% ~ 80%) system, a flow rate of 1 mL/min, and UV monitoring at 
A.292 nm. The multi-display chromatograms (Figure 1.7) verified that SWAT3-wt and 
SW AT3-4 both produced andrimid, while SW A T3-l l l did not. This result is consistent 
with the V. cholerae-antagonistic activity of SW AT3-wt and SW AT3-4 and the lack 
thereof by SW A T3- l l l. 
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Figure 1.7. HPLC Chromatograms of Andrimid and the Crude Extracts of 
Three SWAT3 Strains 
The effect of temperature on andrimid production by SW A T3 was next 
examined. This aim was achieved by quantitative HPLC. The Beer-Lambert Law states 
the linear relationship between absorbance and concentration of a species in the 
equation (2): 
A=a·b·c (2) 
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where A stands for the measured absorbance, a (lambda) is a wavelength-dependent 
absorptivity coefficient, bis the path (cell) length, and c is the concentration of the 
compound giving the absorbance. To calculate the concentration of andrimid in crude 
extracts, a standard curve of absorbance versus concentration was first plotted using a 
pure andrimid standard. Serial dilutions of andrimid in methanol (MeOH) were 
analyzed by HPLC (Hitachi® equipped with L-7455 diode array detector and L-7200 
autosmapler; Symmetry® C18 3.5 µ,m, 4.6 x 75mm column) using the following 
conditions: 10 µL of the injection volume, gradient aqueous methanol (with 0.1 % 
formic acid) (40%-65% over 15 minutes and then 65%-100% over 5 minutes), a 
flow rate of 1 rnIJmin, UV detection at A.292 nm. The andrimid peak eluted at 17 
minutes. UV absorbance was measured for three replicates at each concentration (Table 
1.7). The standard curve was then plotted using the absorbance average of each 
replicate set (Figure 1.8). The standard curve equation (3) was calculated to be: 
y = 13531059 x + 277399 
where y represents the absorbance of the andrimid, x represents the concentration of 
andrimid, and R2 = 0.99853. 
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(3) 
Table 1.7 
UV Absorbance of Andrimid at Different Concentrations 
Concentration Absorbancel Absorbance2 Absorbance3 Aver~e SD 
0.825 m~mL 10723009 11817314 11435248 11325190 555392 
0.400 m_gL_mL 6169920 6252562 5115765 5846082 633822 
0.200m~mL 4341035 2409038 2813440 3187838 1018962 
O.lOOm~mL 1829021 1324538 1661728 1605096 256965 
0.050 m_g/mL 1111343 869316 861500 947386 142044 
0.025 m~mL 491461 351179 364860 402500 77346 
Note. The replicate average and the standard deviation (SD) are also shown (Raw data, n=3). Absorbance was 
measured using a Hitachi L-7455 diode-array detector monitoring at a 292 run wavelength. 
Ten replicate cultures of SW AT3-wt were inoculated into 100 mL of sterile YP 
broth. These ten replicates were divided into two groups of five. Group A was 
incubated at 24 °C, and group B was incubated at 30 °C. All other conditions were kept 
constant. After four days incubation, 100 mL culture was extracted with 2 x 50 mL of 
ethyl acetate, dried over Na2S04, and concentrated in vacuo. All ten dried crude 
extracts had the same physical properties (brown-yellow solid) and were weighed 
(Table 1.8). 
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Figure 1.8. Standard Curve of Andrimid, Absorbance vs. Concentration 
Note. The error bars are the standard deviation, n=3. 
Table 1.8 
The Yield of Crude Extracts of SWAT3-wt Cultures Grown at 24 °C and 30 °C 
licates 1 
8.7m 
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Each of the ten extracts was dissolved in methanol at 3.3 mg/rnL and analyzed 
by HPLC using the identical conditions as above. Table 1.9 shows the absorbance of the 
andrimid peaks in the crude extracts. Concentrations of andrimid in the crude extract 
solutions were then calculated using equation (3). The mean concentration of andrimid 
for group A (24 °C) was 0.166 ± 0.029 mg/rnL and for group B (30 °C) was 0.021 ± 
0.017 mg/rnL (Table 1.10). Using equation (4), the percentages of andrimid in the crude 
extracts were calculated to be 5.03% in group A and 0.64% in group B (Table 1.11). 
__ C_o_n_c_e_n_tr_at_i_on---"'an=dri=·m=i=d- x 100% = % andrimid in crude extract 
Concentration crude extract 
The average of andrimid yielded per lOOrnL of SWAT3-wt culture was 0.43 mg for 
group A and 0.05 mg for group B (Table 1.11, Equation 5). 
Mass crude extract x % andrimid in crude extract = Mass anc!rimid 
24 
(4) 
(5) 
N 
Vt 
Table 1.9 
The Absorbance of Andrimid in the Crude Extracts of SW AT3-wt Culture Incubated at Two Different Temperatures (n=5) 
Absorbance 1 2 3 4 5 A verag_e ± SD 
Grol!Q_A-24 °C 3030300 2326155 2030394 2404887 2800203 2518388 ± 354809 
Gro~B-30 °C 868534 729108 324281 353192 562911 567605 ± 210638 
Table 1.10 
The Calculated Concentration of Andrimid in the Crude Extract Solution (rng/mL) (n = 5) 
Concentration l 2 3 4 5 A vera_g_e ± SD 
Gro~A-24 °C 0.203 0.151 0.130 0.157 0.186 0.166 ± 0.029 
Gro~B-30°C 0.044 0.033 0.003 0.006 0.021 0.021±0.017 
Table 1.11 
The Average Yield of Andrimid per 100 rnL of SW AT3-wt Culture at Two Different Temperatures 
Tem_E_erature ConcentrationT andrimid Concentration crude % of andrimid in crude extract Yield2crude extract Yield3 andrimid 
Gro~A-24 °C 0.166 ± 0.029 m_gLmL 3.30 m_gLmL 5.03% 8.5 m_g_ 0.43 m_g_ 
Gro~B-30 °C 0.021±0.017 mJimL 3.30 m_gLmL 0.64% 7.6 m_g_ 0.05 m_g_ 
Note. 1 Refer to table I. I 0. 2• 3 Yield of crude extract or andrimid per I 00 mL of SW AT3-wt culture. 
( 1.3 Summary and Discussion 
Several lines of evidence support that andrimid is the agent responsible for the 
observed antagonistic interaction directed at V. cholerae by SWAT3. First, andrimid is 
a potent inhibitor of V. cholerae growth. Ve N16961 was susceptible to the antibiotic at 
a concentration of -0.1 µM, comparable to the potency of tetracycline against this 
bacterium. Second, the antagonistic GFP-mutant SW AT3-4 produces andrimid in a 
quantity comparable to the wild-type, while the non-antagonistic mutant SW AT3-111 
does not produce the antibiotic. The production of andrimid by SWAT3-4 is therefore 
the likely mechanism by which it inhibits colonization of model particles by Ve N16961. 
Table 1.12 
The Correlation Between the Production of Andrimid and the Bioactivity of SWAT3-
wt, SWAT3-4 and SWAT3-111. 
V. cholerae-antagonistic activity Andrimid in crude 
Burkholder Ass<!i Crude extract extract (HPLC) 
SWAT3-wt + + + 
SWAT3-4 + + + 
SWAT3-111 - - -
Note. 1 This assay was done by the collaborators. 
The temperature dependency of the SWAT3 antagonism of V. cholerae appears 
to be related to a decrease in andrimid production at higher temperatures. In fact, an 
eight-fold decrease in compound biosynthesis was observed as the incubation 
temperature was raised from 24 °C to 30 °C. V. cholerae was only slightly less sensitive 
to andrimid at higher temperatures in the broth dilution assay (IC50 = 0.08 µM at 24 °C, 
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0.12 µ,Mat 28 °C, and 0.14 µ,Mat 30 °C). These small decreases in susceptibility are 
likely due to faster growth rates of the bacterium at higher temperatures, and should not 
account for the significant differences in bacteria-bacteria antagonism observed in the 
modified Burkholder assay (Table 1.1). 
The combined results of this study (Table 1.12) suggest that bacteria-bacteria 
antagonism by indigenous bacteria may be a mechanism that keeps the proliferation of 
V. cholerae in check in the marine environment. However, the observed temperature 
dependencies of these interactions suggest that V. cholerae may gain a competitive 
advantage under warmer conditions. 
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CHAPTER2 
Biosynthesis of CNC352.223, a Novel Metabolite of Polyketide Origin 
Produced by a Marine-Derived Aspergillus niger 
A structurally novel compound was isolated from a marine fungus Aspergillus 
niger in a previous study. The carbon skeleton of this molecule was predicted of 
pentaketide origin. This chapter describes my studies of the biosynthetic pathway of this 
compound. Methods included the conduction of the stable isotopic feeding experiments 
using 13C singly and doubly labeled sodium acetate, the isolation and purification of the 
target substrates, and 13C NMR analyses of labeled substrates. 
2.1 Introduction 
During the course of an investigation to discover novel inhibitors of the viral 
enzymes HIV integrase and the topoisomerase of the Molluscum contagiosum virus, a 
structurally novel compound, CNC352.223 (1, Figure 2.1), was isolated from the 
mycelium of a marine-derived Aspergillus niger van Tieghem (Wang, 2003b). 
Although (1) lacked inhibitory activity against the two targets, it was proposed to be a 
structurally unique metabolite. An unprecedented structural feature of (1) is a fused 
bicyclic ring system comprising pyrone and pyrrolinone heterocycles. CNC352.223 
possesses a novel carbon skeleton, and with the inclusion of the nitrogen atom, derives 
from mixed biosynthetic pathways. 
A plausible biogenic origin of the carbon skeleton is hypothesized in figure 2.2. 
Given that the molecule contains ten carbons, a pentaketide precursor can be easily 
imagined. Pentaketides are formed by sequential enzyme mediated condensation 
30 
reactions of an acetyl CoA starter unit with four molecules of malonyl-CoA (Herbert, 
1989a). Classic Dieckmann cyclization (McMurry, 1988) of pentaketide (2) followed 
by aromatization would result in the proposed precursor (3). Bayer-Villager type ring 
expansion via an arene oxide intermediate (Iijima et al., 1983; Herbert, 1989b) could 
lead to the substituted 7H-oxepin-2-one (4). Ring opening via ester hydrolysis followed 
by isomerization of the alkene bond and subsequent reformation of the lactone with the 
C9 hydroxyl would result in pyrone (5). Hydroxylation of C3 and ring closure of the 
pyrrolinone ring via introduction of a nitrogen atom would give the completed 
metabolite (1). 
To explore the above hypothetical biogenic origin of (1), feeding experiments of 
the producing A. niger isolate were undertaken using 13C-labelled substrates. 
Specifically, singly and doubly labeled sodium acetates were provided to the fungus 
over a period of ten days, and the labeled compound (1) was then isolated from each 
experiment and analyzed by 13C NMR spectroscopy. 
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2.2 Methods and Results 
2.2.1 Stable Isotopic Feeding Experiments 
Frozen stock (-80 °C) of a marine fungal strain identified as Aspergillus niger 
van Tieghem was thawed at room temperature and transferred into 20 mL of YPM broth 
(2 g peptone, 2 g yeast extract, 4 g mannitol in 1 L of filtered seawater). After five days 
of static incubation at 24 °C, the fungal mycelium was macerated with a spatula and 
evenly distributed into 6 L (6 x 1 L) of fresh YPM broth. The inoculated cultures were 
then divided into three groups (2 x 1 Leach) that were each cultivated using different 
isotopic feeding schemes over ten days. Group A was fed with 250 mg of singly 
labeled sodium acetate (CH3COONa-l- 13C) on days two, four, six and eight. Group B 
was fed with doubly labeled sodium acetate (CH3COONa-l,2- 13C2) using the identical 
schedule. Group C received no additional nutrient. All one-liter cultures formed 
mycelial mats thick with black hyphae over the ten day experiment with no obvious 
morphological differences between them. On the tenth day of incubation, the cultures 
were each filtered through cheese cloth and the liquid portions were discarded. The 
mats from Groups A, B, and C were each frozen and lyophilized for chemical 
investigation. 
2.2.2 Isolation and Structural Examination of 13C-Labeled CNC352.223 Substrates 
Figure 2.3 outlines the isolation and purification of CNC352.223 from the three 
different feeding experiments. The dried mats were extracted with methanol and 
dichloromethane (1:1), and concentrated in vacuo to yield crude extracts (yellow-green 
chunky solids). Fractionations were pursued using reverse phase column 
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( chromatography (Flex® 30 x 200 mm columns packed BAKERBOND™ Octadecyl 
resin, 40 µm, Prep LC packing, LOT: T27085) using a stepwise methanol gradient in 
water (10% - 20% - 30% - 40% - 50% - 60% - 75% - 100%, 200 rnIJeach). 1H NMR 
spectra of these fractions suggested that (1) was concentrated in the 10% and 20% 
fractions. The 10% fraction from Group B (doubly-labeled) was further purified by 
HPLC (X-Terra® Prep RP C18 column, 100 x 19 mm) using a linear 15% - 30% gradient 
of methanol in water (25 minutes, 10 rnIJminute flow rate, 0.1 % formic acid was added 
to each solvent). Fractions were collected based on UV monitoring at a wavelength of 
217 nm. The desired material eluted after eight minutes. Trituration of the dried, light 
brown solids with methanol yielded pure (1) from Group B. Trituration of the 10% and 
20% fractions of Groups A and C directly led to purification of (1). For the purposes of 
discussion, compound (1) isolated from each treatment group will be referred to as 
CNC352.223-S (Singly-labeled, from Group A), CNC352.223-D (Doubly-labeled, from 
Group B), and CNC352.223-N (Non-labeled, from Group C). 
2.2.3 Investigation of the Biosynthesis of CNC352.223 by 13C NMR Analyses of 
Labeled Substrates 
CNC352.223 obtained from each labeling experiment was dissolved in DMSO-
d6 at a concentration of 19.5 mg/mL, and 13C NMR spectra were acquired using 3700 
scans (Figures 2.4-2.6). 
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Figure 2.3. The Flow Chart of the Isolation and Purification of CNC352.223 from All Three Different Feeding Experiments 
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Figure 2.5. 13C NMR Spectrum of CNC352.223-S in DMSO-d6. 
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Figure 2.6. 13C NMR Spectrum of CNC352.223-D in DMSO-d6. 
Note. The amplified peak at 874.8 is displayed as a diagram. The peak in the center is the singlet resulted from the resonance of natural abundant 13C. The two 
smaller peaks on either side are the doublets (also called satellites) resulted from the 13C- 13C coupling of two adjacent 13Cs. 
The 13C incorporations from the labeled acetate feeding experiments are 
consistent with the proposed biosynthetic hypothesis. In the 13C NMR spectrum of 
CNC352.223-D (experiment 2, fungus fed with l,2- 13C2 labeled sodium acetate), 
doublets from 13C-13C coupling could be observed in all ten resonances (Figure 2.6). 
13C- 13C coupling arising from naturally abundant 13C isotope (1.1 % of all carbon) is 
essentia11y negligible (1.1%x1.1%=0.0121 %). Thus, the obvious doublets shown in 
figure 2.6 are the result of incorporations of doubly labeled acetate by the fungus in the 
biosynthesis of (1) (Casey et al. 1976). The specific incorporations (Renner et al., 2000) 
and coupling constants (Table 2.1) are consistent with a pentaketide precursor and the 
hypothetical biosynthetic pathway (Figure 2.2). The fo11owing carbon-carbon pairs 
share similar specific incorporation values and the coupling constants, demonstrating 
that each derives from an intact acetate unit: C2-C3, C4-Cl0, C5-C6, C8-C9, and Cll-
Cl2. This coupling pattern is entirely consistent with the proposed structure (Figure 
2.1). 
Instead of the satellites that are observed in the 13C NMR spectrum of 
CNC352.223-D, enriched singlets are present in the 13C NMR spectrum of 
CNC352.223-S. Since the culture was fed with singly labeled sodium acetate [l-13C], 
only the carbons in the molecule that originate from the carbonyl carbon of the labeled 
acetate should show enrichment over natural abundance. Based on the proposed 
biosynthetic pathway (Figure 2.2), carbon atoms C2, C4, C6, C9, and Cl 1 were 
predicted to show enrichment. Indeed, isotopic enrichments in C2 (0.30%) and C9 
(l.16%) are consistent with the hypothesized biosynthesis. However, enrichments of 
less than 0.22% (or 20% relative height over the natural abundant signal) were 
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measured for the C4, C6, and Cll, which are lower than the generally acceptable limit 
(Herbert, 1989c) and are therefore not significant. This result is consistent with the 
lower incorporations observed with carbon pairs C4-C10 (around 0.17%), C5-C6 
(around 0.17%) and Cll-C12 (around 0.13%) in experiment 2. Curiously, the 
enrichment difference between C8 and C9 is very high (1.16%) which is also consistent 
with the high enrichment (around 0.5-0.7%) of C8-C9 in experiment 2. The labeled 
pattern obtained from both singly labeled and doubly labeled experiments is displayed 
in figure 2.7. 
HO 0 
12 
0 
N OH 
H 
Figure 2. 7. Labeling Pattern of CNC352.223 from Stable Isotopic Experiments 
Note. Darkened bonds show carbons coupled from [1 ,2-13C2] acetate incorporation. The asterisks represent 
significant enrichment from [I-13C] acetate. 
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Table 2.1 
Stable Isotopic Incorporations Resulting from Feeding Experiment with 13C-
Labelled Acetates. 
[1,2- 13C2]-acetate 11-13C]-acetate 
Position 8 13C 
Specific incorp• l 1Jc,c (Hz) Specific incorpb 
2 168.7 0.26 55.2 0.30 
3 141.8 0.26 56.6 
4 145.6 0.17 65.3 NSEC 
5 111.3 0.17 64.5 
6 164.7 0.17 64.9 NSE 
8 74.8 0.70 53.2 
9 173.9 0.52 53.4 1.16 
10 118.6 0.18 67.1 
11 131.2 0.15 42.3 NSE 
12 18.4 0.12 42.5 
Note. "Specific incorporations (doubly labeled) = % enrichments above natural abundance= I. I% x (combined 
peak height of enriched satellites - the combined theoretical peak height for the same satellites resulting from 
natural abundance coupling) I (peak height of the natural abundance singlet + the combined theoretical peak 
height for all satellites resulting from natural abundance coupling) (Renner et al., 2000). bSpecific 
incorporations (Singly labeled) = % enrichments above natural abundance= I. I% x (peak height of enriched 
singlet - peak height of natural abundance singlet) I peak height of natural abundance singlet. c o significant 
enrichment (NSE): % enrichment was less than the lower limit for accurate determination of incorporation 
(Herbert, l 989c) and so was not considered. 
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2.3 Summary and Discussion 
Isotopic labeling studies of CNC352.223 with singly and doubly labeled 13C-
acetate supported the original biosynthetic hypothesis. From the studies conducted with 
the 13C doubly labeled sodium acetate (experiment 2), satellites were observed on all ten 
resonances, which is consistent with the fungus using acetate derivatives (acetyl CoA 
and malonyl CoA) as precursors to synthesize the metabolite. Comparison of the 
enrichments and coupling constants (1) helped to establish that the following carbon 
pairs were derived from the same molecules of acetate: C2 and C3; C4 and C 10; CS and 
C6; C8 and C9; Cl 1 and Cl2. This coupling pattern strongly supports the proposed 
structure of (1). Different carbon pairs possessed different specific incorporations. This 
was because the uptake rates of the labeled acetate to form individual carbon pairs by 
the fungus were different. The 13C- 13C coupling constants for the three labeled sp2-sp2 
bonds varied based on the substitution patterns (h,3 = 55-56, hio= 65-67, 15,o- 64). 
The sp2-sp3 bond of Cll-C12 was found to have a relatively low coupling constant 
(]j J,l 2 = 42). 
The biosynthetic pathway of the molecule CNC352.223 was further traced 
through the analysis of 13C NMR spectrum of CNC352.223-S . In this case, the carbons 
on the molecule originating from the carbonyl carbon of acetate should show enriched 
singlets compared to those from the non-labeled substrate (CNC352.223-N). This 
incorporation pattern clearly showed that C2 and C9 originate from the carbonyl 
carbons in acetate. Unfortunately, insignificant enrichment prohibits carbons C4, C6 
and Cll from similarly being assigned. 
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The specific incorporations from the doubly-labeled acetate feeding experiment 
(experiment 2, sodium acetate-1,2- 13C2) and the enrichment from the singly-labeled 
acetate feeding experiment (experiment 1, sodium acetate-1- 13C) agreed. Carbon pair 
C8-C9 showed the rughest specific incorporation (-0.6%) in experiment 2 as well as the 
highest enrichment of C9 (1.16%) in experiment 1. It was found that the first acetate on 
a skeleton, "starter unit", tends to get more incorporation than the successive ones 
(Herbert, 1989a). The carbons in the C8 and C9 positions would correspond to the 
fourth acetate unit in the hypothetical pentaketide precursor. It is not clear at this point 
why there is much higher incorporation of labeled substrate at the C8-C9 position. 
In accordance with the proposed biosynthetic pathway, the oxygens at C3-0H 
and C8-0H should not be derived from acetate. The source of these oxygens could 
potentially be revealed through further feeding experiments using 180. 
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CHAPTER3 
Inhibition of Bacterial Cell-Cell Signaling by Metabolites 
Produced by a Marine Halobacillus sp. 
Bioassay-guided fractionation led to the isolation of two arylethylamide 
compounds from the culture extracts of a marine-derived bacterial culture C42, 
identified as a Halobacillus sp. Although these two compounds were previously 
published, their quorum sensing-antagonistic activity was investigated for the first time 
in this thesis research. This chapter describes the screening for microbial inhibitors of 
quorum sensing, optimization of the fermentation conditions of culture C42, bioassay-
guided isolation and structural elucidation of two active compounds, and finally the 
quorum sensing inhibitory properties of these molecules. 
3.1 Introduction 
Rather than living in isolation, many bacteria form a community by 
communication with one another using small molecules called autoinducers (Schauder 
and Bassler, 2001). Autoinducers diffuse through bacterial cell walls, and by sensing 
the accumulation of autoinducers in their local environment, bacteria are able to 
determine their own population density. When the population reaches a minimum 
threshold, back diffusion of autoinducers into the bacterial cells activates specific gene 
expression (Schauder and Bassler, 2001). Therefore, bacteria can regulate phenotypic 
expression in response to population density. This process is referred to as quorum 
sensing (QS). 
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QS was first discovered in the marine bacterium Vibrio fischeri, which uses QS 
to regulate bioluminescence (Hastings and Nealson ,1977; Nealson and Hastings,1979). 
V. fischeri lives in symbiotic association with many marine fish and squid (Whitehead 
et al., 2001), potentially providing light to its hosts for purposes such as attracting prey 
or camouflage (Schauder and Bassler, 2001). In return, V. fischeri obtains a more 
nutrient rich environment compared to that available in sea water (Ruby, 1996; Visick 
and McFall-Ngai, 2000). Bioluminescence by V. fischeri is regulated by QS, a 
population-density dependent behavior. 
Two model types of Quorum-sensing pathways have been described for 
bacterial communication: Luxl/LuxR circuits in over 70 species of Gram-negative 
bacteria using N-acyl homoserine lactone (AHL) as autoinducers; and two-component 
(sensory-transduction) systems in Gram-positive bacteria using oligopeptide or 
autoinducing peptides (AIPs) as autoinducers (Miller and Bassler, 2001; Federle and 
Bassler, 2003; Lazazzera and Grossman, 1998). Figure 3.1 shows a typical QS-pathway 
utilized by Gram-negative bacteria. Specific intra-species communication systems 
enable bacteria to distinguish themselves from others and to regulate their own 
particular behaviors in a population of mixed species (Federle and Bassler. 2003). 
However, the structural similarity of AHL autoinducers does lead to some bacterial 
cross-talk. For instance, Vibrio harveyi has been shown to respond to AHL signals from 
various bacterial species (Federle and Bassler, 2003). Inter-species communication is 
believed to allow bacteria to regulate their specific behaviors based on the self-other 
population ratio (Federle and Bassler, 2003). Autoinduer-2 (Al-2), which is reported to 
be a furanosyl borate diester (Chen et al., 2002; Federle and Bassler, 2003), has also 
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been reported to be involved in inter-species communkation (Bassler et al., 1997; 
Bassler et al., 1993; Bassler et al., 1994). Table 3.1 shows representative structures of 
the different types of autoinducers described above (Schauder and Bassler, 2001; Chen 
et al., 2002). 
QS regulates a number of bacterial behaviors including the expression of 
virulence, the production of antibiotics and the formation of biofilms (Schauder and 
Bassler, 2001; Zhu and Mekalanos, 2003; Lindum et al., 1998). It has been 
hypothesized that some bacteria have evolved chemical mechanisms to disrupt the QS 
of their competitors (Schauder and Bassler, 2001). A major problem throughout the 
history of antibiotic drug development is the continual evolution of the drug-resistant 
strains (Brittain, 1987; Francke and Neu, 1987; Lyon and Skurray, 1987; Schaberg et al., 
1991; Smilack et al., 1991; Klein and Cunha, 1995; Geddes, 2000). The biochemical 
pathways used for QS are widely conserved (Schauder and Bassler, 2001). Thus, the 
discovery and development of QS antagonists may lead to a new generation of 
antibiotics possessing broad-spectrum inhibitory activities. 
In recent studies, compounds that inhjbit QS have been identified. Most notable 
are bromjnated furanones produced by the marine red alga Delisea pulchra (Rasmussen 
et al., 2000) and their synthetic analogs. These molecules inhibit QS in Gram-negative 
bacteria and consequently QS-regulated gene expression. Figure 3.2 shows some 
representative brominated furanones, both naturally occurring and synthetic. Furanone 1 
was reported to inhibit the swarming motility of Proteus mirabilis (Gram et al., 1996), 
as well as inhibit the production of antibiotics and virulence factors by the 
phytopathogen Erwinia carotovora (Manefield et al., 2001). Compound 2 reduces the 
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swarming motility in Serratia liquefaciens MG 1 (Rasmussen et al., 2000), while 3 
inhibits biofilm formation (Hentzer et al., 2002) and 4 the production of virulence 
factors by Pseudomonas aeruginosa (Hentzer et al., 2003). 
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Figure 3.1. A Typical QS Pathway in Gram-negative Bacteria Using 
LuxI/LuxR Circuit 
Note. The AHL autoinducers (open pentagons) are synthesized by the Luxl-like proteins and then diffuse 
out through the cell wall and accumulate. When the autoinducers reach a minimal threshold concentration, 
they diffuse back into the cell and bind to the LuxR-like proteins. The formed complexes then bind to the 
target gene and activate gene expression (Schauder and Bassler, 2001). 
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Table 3.1 
Autoinducers Utilized by Bacteria in Quorum Sensing 
A. N-acyl-homoserine lactone autoinducers B. Oligopeptide autoinducers 
8 . subtilis/QimX 
8. subtilis/CSF 
S. aureus/subgroupl 
S. aureuslsubgroup2 
S. aureus/subgroup3 
0 
V.harveyi: 3-hydro-C4-HSL H - A 
YYN\_l 
OH o 
S. aureuslsubgroup4 
C. Furanosyl borate diester AI-2 v. harveyi 
ADPITRQWGD 
ERGMT 
YSTCDFIM 
' I S-C<O 
GVNACSSLF 
' I S-C<O 
YSTCYFIM 
' I S-C<O 
Note. A: N-acyl-homoserine lactones (AHL) used in Gram-negative bacteria; B: Oligopeptides used by 
Gram-positive bacteria; C: Furanosyl borate diester (Al-2) hypothesized to be involved in inter-species 
communication (Schauder and Bassler 200 I; Chen et al, 2002). 
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Figure 3.2. Some Brominated Furanones with QS-Antagonistic Activity 
Note. 1: 4-bromo-5-(bromomethylene)-3-(1 '-hydroxybutyl)-2(51/)-furanone; 2: 4-bromo-5-(bromomethylene)-
3-butyl-2(51/)-furanone; 3: 5-(bromomethylene)-2(51/)-furanone; 4: 4-bromo-5-(bromomethylene)-2(51/)-
furanone. Compounds I and 2 are derived from the benthic marine red alga D. pulchra. Compounds 3 and 4 are 
synthetic. 
50 
Oligopeptides that disrupt QS have also been isolated from the post-exponential 
culture of Staphylococcus xylosus (Gov et al., 2001) (Figure 3.3). Called RNAill-
Inhibiting Peptides (RIP), these molecules disrupt QS in the Gram-positive bacterial 
strains S. aureus and S. epidermis, consequently preventing toxin biosynthesis. 
Synergistic activity with other antibiotics to prevent biofilm formation by drug-resistant 
Staphylococcus epidermidis has also been shown (Balaban et al., 2003). In other 
instances, AHLs with side chains longer than C8, such as N-decanoyl-L-homoserine 
lactone (DHL), have been shown to inhibit QS systems that use AHLs with shorter side 
chains (McClean et al., 1997). 
YSPXTNF YKPITNF YSPWTNF 
Figure 3.3. RN All-Inhibiting Peptides (RIP) Isolated from Staphylococcus xylosus 
3.2 Methods and Results 
3.2.1 QS-Antagonism Screening of the Library of Crude Extracts Produced by 
Marine Bacteria 
Four hundred crude extracts derived from marine microbial cultures (Rowley 
crude extract library, described in Wang, 2003c) were screened for QS antagonist 
activity. A mutant strain of Chromobacterium violaceum, herein referred to as CV026, 
was used as the bioassay reporter strain and is described below. 
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The Gram-negative bacterium Chromobacterium violaceum produces violacein, 
a characteristic purple pigment. The biosynthesis of this pigment is regulated by QS 
using N-hexanoyl-L-homoserine lactone (HHL) as the autoinducer (McClean et al., 
1997). CV026 is a rnini-Tn5 transposon based mutant of the wild-type C. violaceum 
ATCC31532 (Latifi et al., 1996; Throup et al., 1995). This mutant is defective in the 
production of AHLs, and thus cannot produce violacein (Throup et al., 1995). However, 
pigment production by CV026 can be restored by exogenous addition of AHLs with 
side chains from C4-C8 in length (McClean et al., 1997). The CV026 strain used in this 
project was graciously provided by Dr. David Nelson (URI). 
Synthetic or naturally-derived HHL (Figure 3.4) was used as the autoinducer in 
the screening assay. Naturally-derived HHL was extracted using dichloromethane from 
spent liquid cultures of Serratia liquefaciens MGl (McClean et al., 1997), and is 
hereafter referred to as SLMGl-HHL. The swarming motility of S. liquefaciens MGl is 
controlled by QS using HHL (Eberl et al., 1996). To test the ability of SLMGl-HHL to 
induce violacein production, CV026 was seeded evenly over the surface of LB 10 solid 
agar (composed of 10 g of tryptone, 5 g of yeast extract, 10 g of NaCl and 16 g of agar 
per liter of deionized water). Paper disks loaded with 0.5 mg of SLMGl-HHL extract 
were applied to the CV026 lawns. The plate was incubated at 28-30 °C overnight and 
the resulting pigment production was examined the next day. Figure 3.5 shows a typical 
assay result. The purple zones surrounding the paper disks indicate violacein production 
by CV026 in response to diffusion of HHL from the paper disk. 
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Figure 3.4. N-Hexanoyl-L-Homoserine Lactone (HHL) 
Pigment production induced by HHL Paper disk loaded with HHL 
Growth of CV026 
Figure 3.5. HHL Induction of Violacein Production by CV026 
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3.2.1.1 Agar disk diffusion assay for violacein inhibition. 
The frozen stock of CV026 was allowed to thaw at room temperature (23-24 °C). 
10 mL of fresh LB 10 broth was inoculated with a loop of the thawed CV026 stock and 
incubated with shaking at 30 °C overnight. On the next day, 50 µL of the overnight 
CV026 culture and 50 µL of SLMGl-HHL dissolved in dichloromethane (25 mg/mL) 
were both added to 5 mL of molten 8% semi-solid LB 10 agar (39-40 °C). The mixture 
was vortexed and poured over the top of a LB 10 solid agar plate. Five wells were cut 
from the solidified agar plate. 20 µL of a test sample (25mg/mL in DMSO) was added 
to one of the five wells. 20 µL of DMSO was added to a different well (solvent control). 
A total of four test samples could be assayed in one single plate. The plate was then 
incubated in up-right way at 29-30 °C overnight and the results were examined the next 
day. The desired assay result should show a purple background with an opaque 
yellowish halo surrounding the well loaded with a test sample. The purple background 
is due to violacein production by CV026, while the opaque halo would indicate 
inhibition of QS-mediated pigment production but not microbial growth. A total of 10 
crude extracts were assayed this way. 
3.2.1.2 CV026 screening assay in microtiter plates. 
Limited by the size of the Petri dish holding the LB 10 agar (only four extracts 
could be tested by using one plate), a screening assay using 96-well microtiter plates 
was designed for higher throughput. In this assay, turbid CV026 overnight culture 
(prepared as before) was diluted with fresh LB 10 broth by a 1 to 1000 ratio. The 
SLMGl-HHL solution (25 mg/mL, in DMSO) was added to the diluted CV026 culture 
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( to a concentration of 0.25 mg/mL. This mixture is hereafter referred to as culture-
mixture (CM). The assay set up is diagramed in figure 3.6. 150 µL of CM was added to 
each well in a 96-well microtiter plate except for wells F11 , F12, 011, 012, H11, and 
Hl2. 3 µL of a crude extract (25 mg/mL in DMSO) was added to each well in area 1. A 
total of 80 crude extracts were tested per plate. 3 µL of DMSO was added to wells in 
area 2 (A11, A12, B11, B12, C11 and C12) as the solvent control. 148.5 µL of the 
diluted CV026 and 4.5 µL of DMSO were both added to wells in area 4(Fl1, F12, 011 
and 012) as violacein-negati ve controls (no HHL present). 148.5 µL of LB 10 broth plus 
4.5 µL of DMSO was added to each of the wells Hl 1 and H12 as growth-negative 
control. Wells in area 3 (D11, D12, E11, and E12) contained only CM and served as 
violacein-positive controls. Assay plates were incubated at 26-27°C with shaking. Over 
a length of 2 days (48-72 hrs), solvent control (area 2) and violacein-positive control 
(area 3) displayed turbid bacterial growth and purple color due to violacein production. 
The culture in the absence of HHL (area 4) showed only turbid bacterial growth. The 
color of the cultures in the test wells (area 1) were observed carefully. If the color was 
comparable to those in areas 2 and 3, then test samples were deemed not to inhibit 
violacein production. However, nine of four hundred test extracts resulted in lesser 
pigment production. 
These nine active crude extracts were further examined using the agar diffusion 
assay described above. Only two showed obvious opaque halos and were selected for 
further study. These extracts were derived from cultures C42 and B36. Bacterial strain 
C42 was isolated from a seaweed sample collected from Point Judith Salt Pond, South 
Kingstown, Rhode Island in the summer of 2002. Morphologically, single rod-shaped 
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cells could be observed under microscope (Oil immersion lOOOx). Gram staining 
(Madigan et al., 2003b) and a KOH test (Gregerson, 1978; Halebian et al., 1981) both 
indicated that this bacterium was Gram-positive. C42 survived heat shock (70 °C, 6 
minutes) and grew quickly on YP agar plates (5 g of peptone and 1 g of yeast extract in 
1 liter of filtered seawater), but did not grow on the YP agar plates prepared with fresh 
water (YPF). This bacterium was eventually identified as Halobacillus sp. through 16S 
rRNA sequencing method. In order to explain the chemical mechanism of the 
violacein-inhibition activity of C42, this bacterial strain was cultured in large scale, and 
the crude extract was subjected to bioassay-guided fractionation. 
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Figure 3.6. The Plating Scheme for QS-Inhibition Broth Assay 
Note. Area I: 150 µLCM * + 3 µL test sample in each well (Test Area); area 2: Solvent Control 150 µLCM * + 3 µL DMSO; area 3: 150 µLCM ; area 4: 148.5 µL 
diluted culture** + 4.5 µL DMSO; area 5: 148.5 µL LB 10 + 4.5 µL DMSO. * CM: mixture of the diluted culture and HHL containing MGI extract;** Diluted 
CY026 culture. 
3.2.2 Isolation of Quorum Sensing Inhibitory Compounds C42.191 and C42.205 
Produced by Halobacillus sp. Culture C42 
Frozen stock of C42 (-80 °C) was allowed to thaw at room temperature (22-24 
°C), inoculated into each of two culture tubes containing lOrnL of fresh YP broth, and 
incubated at 24 °C with shaking overnight. On the next day, the light yellow bacterial 
culture in two tubes was transferred to two flasks (1 L x 2 flasks, a total of 2 L) of the 
fresh YP broth and incubated under the identical conditions for eight days. Incremental 
measurements were taken to determine the optimal fermentation time for the production 
of QS-antagonistic metabolites by C42. Starting from the second day of the incubation 
(after one full day of incubation, referred to as day 1), 100 rnL of the culture was 
removed each day from one of the culture flask and extracted with 2 x 75 rnL of ethyl 
acetate. Bioassay of the concentrated extracts from days 1-8 were conducted using the 
agar diffusion assay. The optimal fermentation time for the production of the QS-
inhibitory components by C42 was found to be 5 to 7 days (Figure 3.7). 
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Figure 3.7. QS-Inhibitory Activity of C42 Crude Extracts vs. Fermentation Time 
C42 stock was next cultured in 13 L of fresh YP broth (13 x 1 L) for five and a 
half days under the identical fermentation conditions as used in the optimization 
experiment. After the fermentation, the 13 L of opaque yellow C42 culture was 
centrifuged (Sorvall RC-SB, 8000rpm, 15 minutes) to pellet the cells and the clear 
supernatant was extracted using solid phase chromatography (Kontes® Column 
600x50mm packed with 700mLof wet resin, Diaion®HP-20, Supelco, lot: 10552) and 
eluted using an aqueous acetone mixture in gradient concentrations: 25% (1 L) - 50% 
(1 L) - 75%(1 L) - 100% acetone (3 L). After concentration, the four extracts yielded 
6.28 g (25%), 920 mg (50%), 583 mg (75 %) and 83 .2 mg (100%), of which the 50% 
fraction showed the desired QS-antagonistic activity. 200 mg of this extract was further 
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fractionated using size exclusion chromatography (Kontes® 500x38 mm column packed 
with Sephadex LH-20 resin, Fluka®, Lot: 9041-37-6). A solvent system composed of 
iso-octane, methanol and toluene (3:2: 1) was used to elute the column at a flow rate of 
one drop every five seconds. The eluent was collected into test tubes using a fraction 
collector at a rate of 16 minutes per tube. A total of 145 tubes of eluent were collected 
over the two-day experiment. The individual test tubes of eluent were then combined 
into eight fractions based on silica gel thin layer chromatography (TLC) (Whatman®, 
Lot: 4420222). After vacuum drying, fraction 2 formed a white crystal with yellow 
impurities. This fraction weighed 173.7 mg while all other fractions were each less than 
3 mg. QS inhibition assay showed activity in all eight fractions. Because of the 
abundant supply, fraction 2 was then selected for further investigation. Recrystallization 
in iso-octane (TMP) was accomplished by warming the material in TMP to 29-30 °C 
and allowing to stand at room temperature overnight. White fluffy needle-like crystals 
were filtered and vacuum dried (72.3 mg). 
The purity of the crystal was assessed by analytical HPLC (Hitachi® equipped 
with L-7455 diode array detector, column: X-Terra® RP C 18 column, 3.0 x 100 mm, "A= 
216 nm). Two major peaks were observed with small impurities. Subsequent reversed 
phase HPLC (X-Terra® Prep RP C 18 column, 100 x 19 mm, using 20% ---7 40% 
acetonitrile gradient in water, "A= 216 nm, flow rate of 10 rnUmin) yielded two pure 
compounds (C42.191, 10 mg; C42.205, 29.7 mg). Figure 3.8 shows a flow chart of the 
bioassay-guided fractionation of the C42 culture leading to the two pure compounds. 
These two compounds were both white solids and able to crystallize to form needle-like 
crystals from TMP. 
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Figure 3.8. Bioassay-Guided Fractionation of C42 Culture 
f 3.2.3 Structural Elucidation of C42.191 and C42.205 
~ 
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~'-I 41 c~ 
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Figure 3.9. The Structures of C42.191 and C42.205 
Note. C42. I 9 I : N-(2'-Phenylethyl) lsobutyramide; C42.205: 3-Methyl-N-(2'-Phenylethyl)-Butyramide. 
The structures of C42.191 and C42.205 (Figure 3.9) were elucidated using 
electrospray ionization mass spectrometry (ESI-MS, Mariner Spec®) and nuclear 
magnetic resonance spectroscopy (NMR, Brucker®). For ESI-MS, the compounds were 
dissolved in a methanol: water (1 : 1) + 0.1 % acetic acid solvent system at 2 µglmL to 
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optimize ionization. NMR experiments were conducted in methanol-d4 (MeOD) at a 
concentration of about 15 mg/rnL. 
The MS spectrum of C42.191 showed the two positive ion peaks: [M+Ht m/z of 
192.1 and [M+Nat m/z of 214.1, suggesting a molecular weight of 191(Figure3.10). 
Together with 1H and 13C NMR data, a molecular formula of C12H 17NO was deduced, 
indicating that the molecule would have five degrees of unsaturation. 13C NMR (Figure 
3.12) and Deptl35 (Figure 3.13) spectra showed that the compound had 12 carbons, 
including two identical methyls (819.89), two methylenes (836.53 and 841.84), one 
aliphatic methine (836.29), five aromatic methines (8127.32, 8129.43 (2x), 8129.88 
(2x)) and two quarternary carbons (8140.55 and 8180.07). The more desheilded 
quarternary carbon represents a carbonyl carbon and accounts for one degree of 
unsaturation. Integration of the proton NMR spectrum (Figure 3.11) indicated that the 
molecule possessed 16 hydrogens attached to carbon. Therefore, one of the 17 protons 
was exchangeable in MeOD (-NH). The doublet at 81.06 integrates for six protons and 
suggests two methyl groups coupled to a common methine. The septuplet (lH) at 82.36 
represents a proton from a methine coupled to six protons. A multiplet (5H) at 87 .20 is 
typical of five conjugated protons from a mono-substituted benzene ring, which 
accounts for the remaining 4 degrees of unsaturation. The triplet (2H) at 82.77 
represents a methylene group coupled to another methylene group and the quartet (2H) 
at 83.37 represents a methylene group coupled both to a methylene and to a single 
proton (exchangeable proton). The coupling constants here were not clear enough to 
obtain the proton coupling patterns. The two-dimensional COSY (COrrelation 
SpectroscopY) spectrum (Figure 3.14) clearly indicated that the two methyl groups 
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were coupled to a common methine proton and that the two methylene groups formed 
an isolated spin system. The two-dimensional HMQC (Heteronuclear Multiple 
Quantum Coherence) spectrum (Figure 3.15) provided information on C-H one bond 
coupling. All protons and carbons were subsequently assigned (Table 3.2). 
Table 3.2 
1H and 13C NMR Assignments for C42.191 in MeOD-d4 
Carbon OH oc De_E!: 
1 180.07 C=O 
2 2.36 36.29 CH 
3,4 1.06 19.89 CH3 (2x) 
l' 3.37 41.83 CH2 
2' 2.77 36.53 CH2 
l" 140.55 c 
4" 7.2 127.32 CH 
2", 6" 7.2 129.43 CH (2x) 
3", 5" 7.2 129.88 CH (2x) 
Note. The spectra were recorded in MeOD-d4 (1H: 400 MHz, 13C: JOO MHz). 
Based on molecular formula, 1H and 13C NMR chemical shifts, and spin system 
data, the arylethylamide compound C42.191 was constructed (Figure 3.9). Subsequent 
search of the literature showed that this molecule had been previously reported and 
named as N-(2'-phenylethyl) isobutyramide (Maskey et al., 2002). 
The MS spectrum of C42.205 also shows two positive ion peaks: [M+Ht m/z of 
206.1 and [M+Nat m/z of 228.1, indicating a molecular weight of 205 and the 
molecular formula C13H 19NO (Figure 3.16) with 5 degrees of unsaturation. 13C and 
Dept135 NMR spectra (Figures 3.18 and 3.19) show that C42.205 had 13 carbons 
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( including two identical methyls (822.69), three methylenes (836.59 and 841.89 and 
846.36), one aliphatic methine (827.40), five aromatic methine (CH) (8127.34, 8129.47 
(2x), 8129.81 (2x)) and two quarternary carbons (8140.50 and ol 75.54), of which the 
one with higher chemical shift represented a carbonyl carbon. The integration of the 
proton NMR (Figure 3.17) showed 18 hydrogens. All the spectra (Figures 3.16 to 3.20) 
here indkated that C42.205 has the similar structure as that of C42.191 except that 
C42.205 has one additional methylene. Table 3.3 shows the proton and carbon NMR 
chemical shift assignment for C42.205. Based on molecular weight and 1H and 13C 
NMR chemical shift data, C42.205 was found to be 3-methyl-N-(2' -phenylethyl)-
butyrarnide as previously reported in the literature (Maskey et al., 2002). 
Table 3.3 
1H and 13C NMR Assignments for C42.205 in MeOD-d4 
Numberin_g_ Ott oc De_Q_t 
1 175.54 C=O 
2 2.00 46.36 CH2 
3 2.00 27.40 CH 
4,5 0.90 22.69 CH3 (2x) 
l' 3.39 41.89 CH2 
2' 2.77 36.59 CH2 
l" 140.50 c 
2", 6" 7.2 129.47 CH (2x) 
3", 5" 7.2 129.81 CH (2x) 
4" 7.2 127.34 CH 
Note. The spectra were recorded in MeOD-d4 (1 H: 400 MHz, 13C: 100 MHz). 
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Figure 3.10. Mass Chromatogram (Positive Ion) of C42.19 l 
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Figure 3.13. Deptl35 NMR Spectrum of C42.191 in MeOD-d4 
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Figure 3.14. COSY Spectrum of C42.191 in MeOD-d4 
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Figure 3.15. HMQC Spectrum of C42.191 in MeOD-d4 
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Figure 3.20. COSY Spectrum of C42.205 in MeOD-d4 
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( 3.2.4 QS-Inhibition Activity ofC42.191 and C42.205 
3.2.4.1 CV026-violacein inhibition assay. 
Both C42.191 and C42.205 inhibited QS-regulated violacein production by the 
Gram-negative bacterium C. violaceum CV026. However, optimization and 
standardization of the reporter assay were first necessary to accurately assess these 
properties. 
Synthesized HHL was used in the standard assay. Although HHL extracted from 
S. liquefaciens MG 1 adequately induced violacein production by CV026, the batch 
variability of HHL from different S. liquefaciens cultures was unknown. Also, severe 
emulsions were frequently encountered during the extraction process. In order to 
standardize the CV026 assay, HHL was synthesized de novo via a one-step amide-bond 
formation reaction (Figure 3.22). 728 mg (1 equivalent) of DL-homoserine lactone 
hydrobromide (ICN Biomedicals, Cat No. 157389), 511.2 mg (1.1 equivalent) of 
hexanoic acid (ACROS ORGANICS, Lot No. A015866701), and 1.67 g (1.1 equivalent) 
of HBTU (NOV Abiochem® Lot No. A29504) were added to 60 mL of anhydrous 
acetonitrile and stirred. After 40 minutes, 2.5 equivalents of di-methyl amino pyridine 
(DMAP) was added and the reaction stirred overnight. The next day, the reaction was 
concentrated to near dryness and then partitioned between 200 mL of ethyl acetate and 
200 mL of 0.5 N HCl (Figure 3.23). The organic fraction was subsequently washed 
with 200 mL of saturated NaHC03 and finally 200 mL of deionized water. The clear 
ethyl acetate fraction was dried over Na2S04 and concentrated in vacuo to yield a 
slightly-yellow white solid. The solid was dissolved in 15 mL of ethyl acetate and then 
60 mL of iso-octane (TMP) was added. White solids were observed to precipitate out of 
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solution. The solution was cooled (4 °C) for 3 hours, filtered, and washed with TMP. 
300 mg of a shiny white solid was obtained after drying in vacuo. Comparison of 1H 
NMR spectra with literature values (Chhabra et al. , 1993) verified the material to be 
pureHHL. 
Hexanoic Acid 
HBTU, DMAP 
MeCN 
DL-Homoserine Lactone Hydrobrornide 
Figure 3.22. Synthesis of HHL 
N-Hexanoy-DL-Homoserine Lactone (HHL) 
The pure HHL was tested for QS-induction of violacein production. 30 µL of 
the HHL dissolved in acetonitrile (2-fold serially dilutions at concentrations from 0.64 
mg/mL to 0.32 mg/mL ~ 0.16 mg/mL ~o.08 mg/mL ~o.04 mg/mL) along with 50 
µL of the overnight CV026 culture were added to 5 mL of molten 8% semi-solid LB 10 
agar. The mixture was vortexed and poured over the top of a normal LB 10 agar plate. 
The solidified agar plates were then incubated overnight at 29-30 °C. The next day, the 
plates showed sequentially lighter purple color with decreasing concentrations of HHL. 
0.08 mg/mL was the boundary concentration. 0.1 mg/mL was selected to be the 
concentration of HHL used in the agar diffusion assay. 
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Reaction mixture (60 rnL) ! RV to near dryness 
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Add 1) EtOAc (200 rnL) 
HCl 
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2) 0.5 N HCl (200 rnL) 
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EtOAc ! Na2S04, filter, RV 
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l Recrystallization EtOAc: TMP (1 : 4) 
HHL 
Figure 3.23. Purification of Synthetic HHL 
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Two quorum sensing inhibitors were synthesized to serve as active controls in 
the agar diffusion assay. N-decanoyl-L-homoserine lactone (DHL) (McClean et al., 
1997) was synthesized using the same methodology as was used to prepare HHL, only 
decanoic acid (ALDRICH® Lot No. 03722BA) was used instead of hexanoic acid 
(Figure 3.24). 
Figure 3.24. N-Decanoyl-L-Homoserine Lactone (DHL) 
A second quorum sensing inhjbitor synthesized was 4-bromo-5-
(bromomethylene)-2(5H)-furanone (Figure 3.25). The two step reaction sequence is 
shown in figure 3.26 (Manny et al., 1997). 
H 
Br 
0 
H 
0 
Figure 3. 25. 4-Bromo-5-(Bromometh y Jene )-2( 5 H)-Furanone 
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The first step was the bromination of keto acid. Br2 (3 .215 rnL, 0.062 mol) was 
diluted with 16 rnL of CHCh and added dropwise to a solution of levulinic acid (3 .251 
g, 0.028 mol) and 12 drops of 30% HBr in AcOH in 30 rnL of CHCI). The resulting 
mixture was then heated slowly to 58 °C over 50 minutes, refluxed at 58 °C for 70 
minutes, and then cooled to room temperature. The reaction mixture was washed 
sequentially with 40 rnL of H20 , 40 rnL of 0.5 M Na2S20 3, and finally 50 rnL of 
saturated NaCl solution. The organic layer was dried over Na2S04 and concentrated in 
vacuo. This dried material was used directly for the next step. 
The second step was acid-promoted lactone formation . 30 rnL of H2S04 (98%) 
was added to the material obtained from the first step. The mixture was heated at 110-
125 °C for 25 minutes. The hot acid solution was then slowly poured over crushed ice in 
a 200 rnL-beaker. Dark oil that did not dissolve in the ice water could be observed at the 
bottom of the beaker. Using a separation funnel , the whole mixture was then extracted 
with 100 rnL x 3 of dichloromethane (DCM). The dark oil material went into the 
organic solution easily. The DCM extract was then washed with 200 rnL of water, dried 
over Na2S04, and concentrated in vacuo. 
Proton NMR analysis of the crude product showed it to be a mixture of 
brominated furanones with different bromo-substitutions (Manny et al. , 1997). 
Therefore, the crude product was purified as shown in Figure 3.27. First it was 
fractionated by vacuum liquid chromatography on silica-gel (KIMAX®funnel Lot No. 
28400 packed with silica gel, SELECTO® Lot: 306087204, 2 cm thick) by eluting with 
200 rnL of the solvents as follows: 100% TMP ~ 5% TMP in EtOAc ~ 10% TMP in 
EtOAc ~ 25 % TMP in EtOAc ~ 50% TMP in EtOAc ~ 100% EtOAc. The desired 
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compound shown in figure 3.25 was recognized by proton NMR spectra to reside in the 
5% and 10% fractions. These two fraction were therefore combined and 60.5 mg was 
further purified by silica gel column chromatography (Kontes® 300 x 26 mm pack with 
silica gel of 260 x 26 mm, SELECTO® Lot: 306087204, isocratic elution with 1 % 
EtoAc in TMP). 47 tubes of 25 mL each were pooled into 3 fractions based on thin 
layer chromatography analysis and concentrated in vacuo. Proton and carbon NMR 
spectra verified that the third fraction contained the desired product (Manny et al., 
1997). 
Step 1 
Br2 C02H 0 
30% HBr in AcOH 
Levulinic acid Reflux, 58 °C Brorninated acid 
Figure 3.26. Synthesis of Brominated Furanones 
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Figure 3.27. Purification of 4-Bromo-5-(Bromomethylene)-2(5H)-Furanone (Frac.3) 
Inhibition of quorum sensing-mediated violacein production in CV026 by 
C42.191 and C42.205 was then examined. The assay was conducted as previously 
described. Synthetic IIlIL was used to induce violacein production by CV026 (30 µ,L of 
IIlIL at 0.1 mg/mL in acetonitrile were added to each plate). Synthetic DHL and 
dibromofuranone served as active controls due to their published QS-inhibitory activity. 
The paper disks (BBL™ 6mm of diameter) were loaded with 20 µL of acetonitrile 
(solvent control), DHL (three disks impregnated with 0.2 mg, 0.02 mg, and 0.002 mg), 
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dibromofuranone (0.2 mg), C42.191 and C42.205 (four disks each impregnated with 
0.5 mg, 0.2 mg, 0.02 mg, and 0.002 mg). The loaded paper disks were air dried and 
applied over the top of the solidified LB 10 plates seeded with 50 µL of the CV026 
culture. The plates were then incubated at 29-30 °C overnight. The assay plates were 
then monitored for a period of 5 days. On the first day, DHL showed obvious QS-
antagonistic activity. In contrast to the purple background, the disk loaded with 0.2 mg 
DHL displayed a 33.5 mm diameter opaque halo; 0.02 mg of DHL resulted in a 32.5 
mm halo, and 0.002 mg of DHL produced a 25 .5 mm diameter halo. However, DHL 
lost its activity gradually over a period of 5 days. Both C42.191 and C42.205 showed 
QS-antagonistic activity in this assay on disks impregnated with 0.5 mg of compound. 
Opaque halos of 10 mm and 12.5 mm were observed for C42.191 and C42.205, 
respectively. Interestingly, bioactivity of both C42.191 and C42.205 were constant over 
the length of the assay (Figure 3.28). The dibromofuranone at 0.2 mg showed obvious 
antibacterial activity since it resulted in a clear (killing) zone with a diameter of about 
35 mm. Thus, its ability to inhibit QS could not be determined in this assay. 
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Figure 3.28. QS-Antagonistic Activity of DHL, C42.191 and C42.205 
Note. The diameter of the inhibitory zone includes 6mm of the paper disk. 
3.2.4.2 Green fluorescence protein assay. 
The inhibitory activity of C42.205 against the production of green fluorescent 
protein (GFP) by E. coli JB525 was also examined. 
E. coli JB525 harbors plasmid pJBA132 and expresses unstable GFP in response 
to C6-C8 AHLs (Anderson et al., 2001; Wu et al., 2000). This strain served as a second 
reporter strain for the studies here. Modified LB broth containing 4 g of NaCl was used 
to culture E. coli JB525 at 30 °C on a rotary shaker overnight. On the next day, the thick 
opaque culture was diluted to the OD450 of 0.242 and then treated with 10 µ,L of a HHL 
solution (0.458 mg/mL in DMSO, final concentration of HHL at 100 nM). This cell 
culture-HHL mixture is hereafter referred to as CC-HHL. Eight culture tubes containing 
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a 30 mL of CC-illIL each were then treated with different concentrations of C42.205 
(Table 3.4) and incubated at 30 °C with shaking. lmL aliquots were withdrawn from 
each tube at 0 hr, lhr, and 2hrs, and measured for optical density (OD450) and 
fluorescence (A.ex= 475 nm, A.em= 515 nm). The results are shown in table 3.5. 
Relative fluorescent units (RFU) were divided by OD to normalize for cell density as 
shown in the following equation: 
RFU/OD = (FLsample-FLblank) I (ODsample-ODblank). 
Figure 3.29 shows the RFU/OD as a function of time. Over the length of the 
assay, 1.2 mM of C42.205 completely inhibited GFP production. Activity decreased as 
a function of concentration decreases, with the lowest concentration tested (1.96 µ.M) 
still showing obvious inhibitory activity. 
Table 3.4 
The GFP Assay Set Up and the Serial Concentration of C42.205 
Tube Pre..E_aration Concentration of C42.205 
1 29.8 mL CC-illIL + 0.2 mL DMSO Solvent Control 
2 29.8 mL CC-illIL + 0.2 mL C42.205 6mM 
3 29.8 mL CC-illIL + 0.2 mL C42.205 1.2mM 
4 29.8 mL CC-illIL + 0.2 mL C42.205 240 µ.M 
5 29.8 mL CC-illIL + 0.2 mL C42.205 48 µ.M 
6 29.8 mL CC-illIL + 0.2 mL C42.205 9.6 µ.M 
7 29.8 mL CC-illIL + 0.2 mL C42.205 1.92 µ.M 
8 30.0 mL diluted cell culture Bacterial Growth 
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Tabe 3.5 
Measured Fluorescence and Optical Density 
Ohr lhr 2hr 
Culture tube FL OD FL OD FL OD 
Tube 1 HHL lOOnM 34.883 0.646 52.196 0.809 48.407 0.645 
Tube2 C42.205 6000JLM 32.817 0.618 32.905 0.766 34.243 0.729 
Tube 3 C42.205 1200JLM 32.296 0.647 33.299 0.775 33.739 0.825 
Tube4 C42.205 240JLM 32.862 0.619 39.273 0.802 37.379 0.878 
Tube 5 C42.205 48JLM 33.437 0.639 44.788 0.808 44.256 0.972 
Tube6 C42.205 9.6JLM 35.329 0.656 50.373 0.772 47.615 0.948 
Tube7 C42.205 l.92JLM 36.265 0.624 51.241 0.845 48.711 0.821 
Tube 8 Bacterial growth 32.013 0.675 32.462 0.758 32.676 0.766 
Blank LBcBroth 33.657 0.371 32.850 0.374 33.850 0.383 
Note. FL, A.ex= 475nm, A.em= 515nm; OD, A.= 450nm. Values represent an average of three readings. 
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3.3 Summary and Discussion 
Bioassay guided fractionation of the culture of a Halobacillus sp. led to the 
isolation of two arylethylamide compounds herein referred to as C42.191 and C42.205. 
Both C42.191 and C42.205 were previously reported to be isolated from a possible 
lirnnic Bacillus sp. culture, but no bioactivity was reported (Maskey et al., 2002). DHL 
and a dibromofuranone compound were synthesized and utilized as active controls due 
to their published QS-antagonistic activity. DHL showed obvious QS-inhibitory activity 
in the CV026 reporter assay. Surprisingly, the dibromofuranone showed antibacterial 
activity, and no obvious QS-inhibitory activity was observed for this molecule in this 
assay. 
Both C42.191 and C42.205 showed certain QS-antagonistic activity. In the agar 
diffusion assay, the violacein-inhibitory zones resulted from C42.191 (dia = 10 mm) 
was slightly less than that from C42.205 (dia = 12.5 mm), both of which were much 
smaller than that from DHL (dia > 35mm at lower concentrations). This is likely due to 
DHL being a more potent inhibitor than C42.191 and C42.205. However, the diffusion 
rate of the three compounds into agar is unknown, and therefore one cannot assess 
absolutely which is more potent based on this assay. An interesting observation was that 
the opaque halos resulting from DHL shrank over the period of assay. This implies that 
CV026 restored its ability to produce the purple pigment over time. In contrast, the 
halos resulting from C42.191 and C42.205 were maintained over the five-day assay, 
perhaps indicating the irreversible nature of the inhibition by these two compounds. 
Alternatively, DHL may not be stable over the length of the assay. In the GFP assay, 
C42.205 showed obvious QS-inhibitory activity. GFP production was completely 
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abolished at 1.2 mM of C42.205, while the lowest concentration tested (1.96µM) still 
showed obvious antagonist activity. 
Interestingly, Gram-positive bacteria such as C42 are not expected to use AHLs 
as cell-cell signaling molecules. It is curious that C42 produces secondary metabolites 
that interfere with a Gram-negative signaling pathway, but does not inhibit bacterial 
growth. This is the first time that metabolites from Gram-positive bacterium have 
demonstrated this type of activity. This result hints at a possible ecological advantage 
for bacteria to jam the communication pathways of their competitors. 
In future studies, further assays, such as the Serratia liquefaciens' swarming 
motility assay, should be employed to more completely explore the anti-quorum sensing 
activity of these molecules. Also, synthesis of analogues of these simple molecules 
should help clarify their important structural features. Like AHLs, arylethylamides also 
possess a ring system with a side chain connected via an amide bond. These 
compounds represent a new chemotype for quorum sensing inhibitors, and synthetic 
manipulation of their unique features may lead to a new generation of molecules to 
combat antibiotic resistance. 
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